Arbutus Biopharma Corp. (ABUS)
4.61
-0.05
(-1.07%)
USD |
NASDAQ |
Mar 02, 10:02
Arbutus Biopharma Price : 4.61 for March 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 52.02 |
| Merck & Co., Inc. | 122.69 |
| Trevi Therapeutics, Inc. | 11.95 |
| ACADIA Pharmaceuticals, Inc. | 23.83 |
| Alnylam Pharmaceuticals, Inc. | 330.64 |
Price Related Metrics
| PS Ratio | 60.35 |
| Price to Book Value | 11.46 |
| Earnings Yield | -4.81% |
| Market Cap | 886.61M |